Literature DB >> 24157724

The benefits of errorless learning for serial reaction time performance in Alzheimer's disease.

Xavier Schmitz1, Nathalie Bier2, Sven Joubert2, Caroline Lejeune1, Eric Salmon3, Isabelle Rouleau4, Thierry Meulemans1.   

Abstract

Identifying the conditions favoring new procedural skill learning in Alzheimer's disease (AD) could be important for patients' autonomy. It has been suggested that error elimination is beneficial during skill learning, but no study has explored the advantage of this method in sequential learning situations. In this study, we examined the acquisition of a 6-element perceptual-motor sequence by AD patients and healthy older adults (control group). We compared the impact of two preliminary sequence learning conditions (Errorless versus Errorful) on Serial Reaction Time performance at two different points in the learning process. A significant difference in reaction times for the learned sequence and a new sequence was observed in both conditions in healthy older participants; in AD patients, the difference was significant only in the errorless condition. The learning effect was greater in the errorless than the errorful condition in both groups. However, while the errorless advantage was found at two different times in the learning process in the AD group, in the control group this advantage was observed only at the halfway point. These results support the hypothesis that errorless learning allows for faster automation of a procedure than errorful learning in both AD and healthy older subjects.

Entities:  

Keywords:  Alzheimer's disease; perceptual motor performance; reaction time; rehabilitation; serial learning

Mesh:

Year:  2014        PMID: 24157724     DOI: 10.3233/JAD-130887

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  1 in total

1.  A framework for rehabilitation for older adults living with dementia.

Authors:  Julie D Ries
Journal:  Arch Physiother       Date:  2022-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.